Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
where do I have to sign ?? LoL
Angelo, right !!
super correct..my bad...that's the problem of writing a message in several steps while doing 5 Others things.
thanks for the correction
is MKN really selling ?
or are they trying some other kind of strategy...?
400 scripts per week....are we kidding ? and with other products the make millions ???
Angelo, in a nutsheel you disclosed my basic investment case...
but market forces are playing hard against IPCI, and IPCI's management as well.
either they make a U turn and start to deliver and deliver and deliver
or market forces will easily win.
QUETIAPINE FUMARATE ER
TRX count - monthly
01/31/2018? 12/31/2017 11/30/2017 10/31/2017 09/30/2017 08/31/2017
2.33k 2.49k 2.91k 3.27k 2.65k 1.74k
TRX count - weekly
02/16/2018? 02/09/2018 02/02/2018 01/26/2018 01/19/2018 01/12/2018
483.00 557.00 506.00 466.00 505.00 543.00
guys, my contribution to the mkt cap/reverse split/new offering debate:
- RS doesn't solve mkt cap, but it does solve minimum 1.00 $
- new offering COULD resolve mkt cap, but does nothing for min 1.00$
that is why, more often than not, you have the 2 combined...BUT....
here lies the problem: we have a force in total control of share price...it has been happening over the last 2 years, but after the AdComm it became clear even to a child.
now, suppose they RS 10:1...price goes to 6$
1- a contextual offering would be priced with at least a 30% discount VERY LIKELY ..let's say @ 4.2 with the disgraceful warrants attached.
2- suppose the want to raise 3mln shares (x 4.2 = 12.6mln cash)
3- they now would have around 38mln shares outstanding so mkt cap is fully solved
4- at this point the shorters, having now 3 different kind of warrants would drive the priced down heavely (we recently went from 1.05 to 0.65 in just 1 month)
5- the price would like reach 3.00$ in a couple of months...which FOR US LONGERS it is like 0.30 !!!!!
conclusion: RS+offering usually has a negative outcome, since the markets consider that the company is running out of options; if the company had partnership, news surprise, short-term positive updates they would release them...that is the reasoning.
bottom line:
- RS+new offering would allow IPCI to regain compaliancy
- would destroy shareholder value
- would devastate company reputation (already low)
- would ignite new and stronger share price manipulation
if IPCI goes that route...we shareholders are DEAD.
Wimike, agreed...a new offering would push us very likely on OTC.
Now, if the company doesn't act quickly and strongly it would be inevitable we all will end up with a bunch of dollars in hands. At this point I do hope the two funds for to 20-25% of the company and tart to change it upsidedown, forcing the doctors in the lab
18 out 25....red candles since the China leak...
yes mrs Odidi and Patent...we are sure share price is Beyond your control...
it is SOMEONE ELSE's control...for sure.
while you think if/when/which contract/Agreement to sign IPCI systematically loose value.
just hope activists are about to take control ownership; what??? they are not the solution ?? Likely...but better off than free falling like for ever
shame on the manegement
Angelo, here you have (sorry ...the format is a mess)
The problem with sales data is that we don't know which Bloomberg filter gives the most appropriate data.
DEXMETHYLPHENIDATE HCL ER
01/31/2018? 12/31/2017 11/30/2017
TRX dollars 5.29M 5.77M 6.97M
Tot prescrip manufact bench sales dollars 4.11M 4.49M 5.41M
QUETIAPINE FUMARATE ER
01/31/2018? 12/31/2017 11/30/2017
TRX dollars 1.49M 1.62M 1.91M
TRX MBS $ 83.19k 88.83k 104.63k
02/16/2018? 02/09/2018 02/02/2018 01/26/2018 01/19/2018 01/12/2018 01/05/2018 12/29/2017 12/22/2017 12/15/2017 12/08/2017 12/01/2017
TRX dollars: 328.14k 376.07k 354.62k 272.03k 336.33k 321.34k 367.66k 320.37k 320.37k 412.27k 424.12k 489.86k
TRX MBS $: 19.13k 20.80k 18.60k 15.93k 19.09k 18.39k 19.72k 17.28k 18.34k 23.26k 22.75k 26.36k
wimike,
whatever the management says, thinks or does, it seems there is ALWAYS one element missing in the equation:
TIME is MONEY
the more time goes by without concrete developments and the less the company is Worth.
now, why they don't get it ?
suppose tomorrow they announce a Regabatin partner...we do what..triple ?? and yet we are at much lower prices than before the AdComm.
this is the ONLY way we get out from being shorted - whithin 9 months from now:
1 - china partnership announcement
2 - Regabtin partnership
3 - Purdue lawsuit partnership
4 - Prodras human studies + partnership
5 - 2 more ANDAs approvals
Fantasy ? Likely...but that is the only way out from shorters/manipulators...
The risk of being bought out at some point if we continue the downfall is increasing...but unlekely we can hope for more than 1$
Seroquel - Focalin as of 16 feb...nothing is moving guys, TRX count, sales, benchmark sales...whatever filter...both PAR and MKN delivered slightly less than the previous week.
wimusky, all very plausible and with logic.
on point 4): moving generics to China makes more sense if they are planning to use Canada facilities for something else...which would likely be Oxy and Regabatin .
we could have, over the next few months:
- china partnership
- regabatin partnership
- oxy settlement + partnership (still consider a Purdue partnership a possibility)
- 2 more ANDAs approval
enough for a normal biotech to make a 10x from here....I would be happe to be back @ 3.00
The point is share price is always pushed down...no matter which the news is.
So there is a clear problem that a listed company MUST in someway address.
I don't understand how can Odidi be so stubborn to not understand that is driving us against a wall... because the more we go down and the more the delisting becomes a possibility.
Or maybe he already knows we are going there and he is fine with that.
Sorry guys, but instead of writing 20 msgs about Samsa would be more interesting for those who didn't have the opportunity to listen to the conf call (like myself) which are your takes.
Useless speaking about the share price, we are going to be crashed down unless a partnership is signed at the soonest (we have very tiny cash).
before october 2016 we had no institutions holdings in ipci; now we have two funds owing around 9%. almost nobody commented (except doog and wimusky).
IPCI has always a way to surprise...now the missed the earnings released date...LoL
now either they are going to realease them just before eranings call
or they are missing the easrnings call as well
just hope (or dream) this has something to do with a positive update...keep repeating myself I have to have faith...yes, but do not make Investments based on faith...let's see if I will be once again feeling dumb&dumber.
interestingly, Sabby Management, as of 31st of december also sold 849K usd of Eagalet, almost zeroing out the position.
the position just created with ipci represents 0.66% of Sabby portfolio
Armistice Capital zeroed out 2.6Mln usd held in Eagalet
ipci holdings represent 0.20% of Armistice Capital
correct mopar, I remember me and you stressing this out many times before the last offering...
company needs to deliver and increase its value via partnerhips and approvals, which will also solve cash needs.
end of story; a new offering can be considered only if included in a wider strong strategic agreement
Sabby Management: Bloomberg is showing a new position, as of 31 december, Sabby opened a 1'083'637 new positions, 3.12%
Armistice increased by 120'000 shares, now 5.58% of outstaind
First foundation reduced by 105'781, now 1.41%
Bank of Montreal almost reduced to zero, selling 147'155 shares (honestly I think this is just an intermediary account )
Angelo, mopar, we are on the same page...RS does nothing except helping more shorting.
Wim, Bloomberg is showing that as of 31st of jan 2018 the short interest actually inreased, by 107'613 more shares, compared to the two weeks before.
Therefore the China news was likely used to partially cover but, as I wrote in the following days, to open even more above 1.00$.
Everybody remember that shorts figures are 15days delayed; therefore the cover Beach is alluding to would be shown at the end of february (as of 15th of feb)
Anyway I strongly agree with you that the MM is in charge, together with the small Group of traders and with some other influencers...someone has been paying them for quiet a long time now.
just hope this is going to end...for the good
"OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.
The drugmaker said it will inform doctors on Monday that its sales representatives will no longer visit physician offices to discuss its opioid products. It will now have about 200 sales representatives, Purdue said.
"We have restructured and significantly reduced our commercial operation and will no longer be promoting opioids to prescribers," the Stamford, Connecticut-based company said in a statement.
Doctors with opioid-related questions will be directed to its medical affairs department. Its sales representatives will now focus on Symproic, a drug for treating opioid-induced constipation, and other potential non-opioid products, Purdue said.
Opioids were involved in more than 42,000 overdose deaths in 2016, according to the U.S. Centers for Disease Control and Prevention.
Among other opioid producers, Endo International Plc agreed in July to pull its Opana ER painkiller after the Food and Drug Administration called for its withdrawal.
Purdue and other drugmakers have been fighting lawsuits by states, counties and cities that have accused them of pushing addictive painkillers through deceptive marketing.
The lawsuits have generally accused Purdue of downplaying OxyContin's addiction risk and of misleading marketing that overstated the benefits of opioids for treating chronic, rather than short-term, pain.
At least 14 states have sued privately held Purdue. Alabama Attorney General Steve Marshall filed a lawsuit on Tuesday accusing Purdue of deceptively marketing prescription opioids.
Purdue is also facing a federal investigation by the U.S. Attorney's Office in Connecticut.
Purdue has denied the allegations in the various lawsuits. It has said its drugs are approved by the U.S. Food and Drug Administration and account for only 2 percent of all opioid prescriptions.
Purdue and three executives pleaded guilty in 2007 to federal charges related to the misbranding of OxyContin and agreed to pay $634.5 million to resolve a U.S. Justice Department probe.
That year, Purdue also reached a $19.5-million settlement with 26 states and the District of Columbia. It agreed in 2015 to pay $24 million to resolve a lawsuit by Kentucky.
U.S. President Donald Trump has drawn criticism for his response to the opioid crisis. He has yet to declare it a national emergency as he pledged to do in August following a recommendation by a presidential commission. "
https://www.cnbc.com/2018/02/11/oxycontin-maker-stops-promoting-opioids-cuts-sales-staff.html
Exactly Tilator, and as you have seen it is very difficult to not have messages removed but I find the way asking for a transcript to give the info you requested
Thank you so much Doog
Any way to recover the video or transcript of Rexista AdComm?
mopar44o, that would be my first question: why doesn't the company care about share price, given the fact that you are a listed company and you are no longer in compliance with the 2 very requiriments to be Nasaq listed ?
but you won't have any meaningful answer.
Truth is they don't care, beacuse they don't know HOW to preserve shareholders value
AND
they are likely not able to understand the concept of price manipulation.
sprot, that is already proven...no need for betting LoL
As I wrote last week we are approaching 0.70.
Now, the problem with these guys is they don't care about share price and the don't care about shreholders.
Someone else has been very worried about share price having just a downward direction.
Let's just hope Odidi won't be there to answer to conf call quesitons...I so horribly remember the "did you make other studies ?" - "ehm...NO"...during AdComm.
and another aspect it is Worth considering: when it comes the moment to ask NASDAQ for a 6 months extension with regards to the 2 compliance requirements (1.00 price and minimum market cap) if we will be standing @ 0.40 - 0.50$ it is not granted we will have the green light. the more the requirements are far away and the more demanding will be the authority in asking for plans and credible developments.
those who are shorting are betting for:
- new shares offering
- NASDAQ delisting
I am holding strong to my shares but I feel increasingly less comfortable as the time passes without ANY TANGIBLE development on ANY of the open projects.
I am not pessimistic, just realistic
Focalin same number as previous week,
Seroquel 5-6% lower.
Fred is likely right; a new offer is not so far away, those who have been in control of share price know it and they are dancing while waiting for the next big wave of shorts, cover and repeat.
everybody, have a nice week end
It looks like we are preparing for a new dip around 0.70, where our "friends" will cover they shorts opened around 1.00 ten days ago, thanks to the complicity of the market maker (which is anctive part in this design).
then we could have some positive update with earnings, just enough to pop around 1.00 and let the game roll-over again.
we can just hope one day, somebody, somehow will put an end to this traders playground...I can't even imagine how much money they have been made during the last 3 yrs.
just want to see their backs broken...but, is this gonna ever happen ?
fingers crossed
Focalin TRX count 19th Jan (DEXMETHYLPHENIDATE HCL ER)
Par: 4.24K (previous 4.79k)
the Total n of prescriptions was down: 40.31K vs 43.38K
TRX dollars: 1.16mln (previous 1.29mln)
QUETIAPINE FUMARATE ER TRX count
Mallinck 505 (vs 543 previous)
TRX dollars
336K (vs 321K)
Sorry guys...I am un hurry..that's the best I can do today
how can it be possibile that Mr Odidi attended a public cerimony and hoped not to be seen, pictured, mentioned in local news ?
It looks like he is the second time unprepared for big events: AdComm and now China connection.
I have the feeling he is acting for the benefit of IPCI, but this episode and the way it has been managed so far just highlights the incredible risks we incur having an incompetent CEO, when it comes to business matters and duties to shareholders.
it is disappointing to have a potential catalyst which turns out to be the triumph of uncertainty.
I agree Tilator, but nor a negative effect either.
Truth is friday we touched 1.00 and I wrote on this board that likely new shorts have been opening at that level.
I have been saying here many times that I strongly believe we need a transformational partnership to get out of this s..t.
Positive or slightly positive news/updates will just be shorted.
So when a big news will finally hit we will go, say from 0.8 to 3, instead that from 2 to 6 or 3 to 9...that is the permanent damage that this disconnect from price action and company devolpments has brought us.
and this behaviour was evident a long, while me and Samsa many times wrote about it
wimusky, I agree, the update looks good.
But hell no, the gaming is not stopping, and still we have someone controlling the price.
Until we see the disconnect between company development and share price we know it's not over.
And until it's not over, we could have the possibility of bad finance winning over business.
I feel somewhat reassured from a business point of view, I increasingly feel uncomfortable when see the price action.
Sooner or later they have to face this issue.
I know I will sound like in depression, but honestly this Whole China story it just confirms that IPCI shouldn't be a listed company.
we are now seeing gossip-like news, that if/when confirmed, would rise more than one question about IPCI being compliant with shareholders information duty about material aspects. (which is the secret so secret to be not dislosed about opening a new plant or signing a new deal for production ??)
usually when a news leaks out before what planned, the company puts a PR...
anyway, price action has been the usual one so far....
supposed positive development = negative price reaction
any other company would have seen a price ride just due to speculation...but being down 10% since that picture...at least remaining at friday levels...
This would give us an "interesting" situation.
Wrong:. A VERY interesting situation
My same findings. Hope for a clarification by ipci.
Not easy to find info on China co.
Sorry guys, bit is this link saying that Intelli just openend a plant in China ?
the name intellipharmaceutis in clearly readable in the first picture...
...so shouldn't this be a "material info" to be delivered to the marked with a PR ?
This should open new paths nobody discussed here so far.
Am I missing something...or am I the only one who jumped on his seat ?
My point is the screwed it up... likely receiving some CRL on their Andas applications.
It is like two years that we hear they are expecting one or more approvals by the next 3-6months
The only tiny hope for a news related volume increase Friday remains possible Regabatin partnership.
Now I understand why there has been an increase in shorts even if at historical low prices... somebody knows they did an offer just to fund their salaries, so another one is coming ...very likely.
Only money can come from possible partnership; don't believes the new-andas-approval-fable anymore.
They messed bigtime on generics as well.
Since AdComm failure they didn't deliver anything.
And one more thing; @ ImpactTrader: don't have anything against you, but your credibility is at historical minimum... your msg stressed more than once a big news on Prodras...now it looks like they didn't even started. Either you have been fooled around or you are just playing with us, but why??
Ok, now we know that the last offer was made to grant salaries to Odidi and friends...since it looks like they haven't been progressing on anything.
So what about yesterday? New shorts have been opened @1.00....